{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:49Z","timestamp":1792162789631,"version":"4.4.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160371"],"award-info":[{"award-number":["82160371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360162"],"award-info":[{"award-number":["82360162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20212BAB216051"],"award-info":[{"award-number":["20212BAB216051"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20224ACB216009"],"award-info":[{"award-number":["20224ACB216009"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["202201011395"],"award-info":[{"award-number":["202201011395"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019005","name":"Young Elite Scientists Sponsorship Program by Tianjin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117372","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T06:59:53Z","timestamp":1758783593000},"page":"117372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["Advances in understanding the mechanism of noncoding RNA (ncRNA)-mediated regulation of macrophage polarization in NAFLD"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1018-0629","authenticated-orcid":false,"given":"Chang","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.bcp.2025.117372_b0005","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0010","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.117372_b0015","doi-asserted-by":"crossref","unstructured":"A. Mantovani, E. Scorletti, A. Mosca, A. Alisi, C.D. Byrne, G. Targher, Complications, morbidity and mortality of nonalcoholic fatty liver disease, Metabolism: clinical and experimental 111s (2020) 154170.","DOI":"10.1016\/j.metabol.2020.154170"},{"issue":"9","key":"10.1016\/j.bcp.2025.117372_b0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13757","article-title":"Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank","volume":"16","author":"Lim","year":"2025","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamainternmed.2024.6431","article-title":"A Clinical Update on MASLD","volume":"185","author":"Zhang","year":"2025","journal-title":"JAMA Intern. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117372_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med. (Lond.)"},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0055","article-title":"Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease, Antioxidants (Basel","volume":"9","author":"Monserrat-Mesquida","year":"2020","journal-title":"Switzerland)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117372_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1285473","article-title":"Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.117372_b0085","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41420-022-01061-x","article-title":"The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer","volume":"8","author":"Xu","year":"2022","journal-title":"Cell Death Discovery"},{"issue":"24","key":"10.1016\/j.bcp.2025.117372_b0095","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2502242","article-title":"Efruxifermin in Compensated Liver Cirrhosis Caused by MASH","volume":"392","author":"Noureddin","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117372_b0100","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jhep.2024.10.044","article-title":"Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kim","year":"2025","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2024.07.034","article-title":"Targeting the liver clock improves fibrosis by restoring TGF-\u03b2 signaling","volume":"82","author":"Crouchet","year":"2025","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0110","first-page":"1592","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association","volume":"142","author":"Chalasani","year":"2012","journal-title":"American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology"},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0115","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"issue":"30","key":"10.1016\/j.bcp.2025.117372_b0120","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004836-200304000-00015","article-title":"Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study","volume":"36","author":"S\u00f8rensen","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bcp.2025.117372_b0140","series-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 9(5)","first-page":"428","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","author":"Yasui","year":"2011"},{"issue":"24","key":"10.1016\/j.bcp.2025.117372_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117372_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"Journal of diabetes research"},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0160","first-page":"1313","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology (Baltimore","volume":"41","author":"Kleiner","year":"2005","journal-title":"Md.)"},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063337","article-title":"The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review","volume":"25","author":"Giuffr\u00e8","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117372_b0170","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmet.2025.01.020","article-title":"EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"37","author":"Ma","year":"2025","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0175","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"7783","key":"10.1016\/j.bcp.2025.117372_b0180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0190","first-page":"947","article-title":"Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC, Hepatology (Baltimore","volume":"81","author":"Xia","year":"2025","journal-title":"Md.)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0200","first-page":"317","article-title":"The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment, Liver international : official journal of the International Association for the Study of the","volume":"36","author":"Margini","year":"2016","journal-title":"Liver"},{"key":"10.1016\/j.bcp.2025.117372_b0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/JHC.S272213","article-title":"NAFLD-Associated HCC: Progress and Opportunities","volume":"8","author":"Geh","year":"2021","journal-title":"Journal of hepatocellular carcinoma"},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver Macrophages: Old Dogmas and New Insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatology communications"},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0220","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.stemcr.2016.11.005","article-title":"Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury","volume":"7","author":"Dooley","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12865-018-0261-0","article-title":"Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity","volume":"19","author":"Pavlou","year":"2018","journal-title":"BMC Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0240","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-020-2323-5","article-title":"Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22914","article-title":"Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0255","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","article-title":"Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice","volume":"67","author":"Ma","year":"2017","journal-title":"J. Hepatol."},{"issue":"46","key":"10.1016\/j.bcp.2025.117372_b0260","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"PNAS"},{"issue":"Pt B","key":"10.1016\/j.bcp.2025.117372_b0265","article-title":"MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization","volume":"124","author":"Chang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexmp.2016.07.005","article-title":"M1-\/M2-macrophage polarization in pseudolobules consisting of adipohilin-rich hepatocytes in thioacetamide (TAA)-induced rat hepatic cirrhosis","volume":"101","author":"Wijesundera","year":"2016","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0275","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100444","article-title":"Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP reports : innovation in hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0285","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s40001-023-01488-7","article-title":"Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis","volume":"28","author":"Xia","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bcp.2025.117372_b0290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.019","article-title":"Individualized precision treatment: Targeting TAM in HCC","volume":"458","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12964-024-01489-x","article-title":"MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0300","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0305","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/nar\/gkz097","article-title":"An estimate of the total number of true human miRNAs","volume":"47","author":"Alles","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bcp.2025.117372_b0310","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrg3079","article-title":"Evolution of microRNA diversity and regulation in animals","volume":"12","author":"Berezikov","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0320","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117372_b0325","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fimmu.2020.00625","article-title":"MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases","volume":"11","author":"Pasca","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117372_b0330","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages","volume":"122","author":"Nazari-Jahantigh","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.bcp.2025.117372_b0335","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"O'Connell","year":"2009","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0340","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1182\/blood-2005-01-0191","article-title":"Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism","volume":"105","author":"An","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2025.117372_b0345","doi-asserted-by":"crossref","unstructured":"H. Ying, Y. Kang, H. Zhang, D. Zhao, J. Xia, Z. Lu, H. Wang, F. Xu, L. Shi, MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway, Journal of immunology (Baltimore, Md. : 1950) 194(3) (2015) 1239-51.","DOI":"10.4049\/jimmunol.1402088"},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117372_b0350","article-title":"MiR-9-5p promotes M1 cell polarization in osteoarthritis progression by regulating NF-\u03baB and AMPK signaling pathways by targeting SIRT1","volume":"101","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042971","article-title":"Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1\u03b2 production in macrophages by targeting STAT3","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117372_b0360","doi-asserted-by":"crossref","unstructured":"E. Vergadi, K. Vaporidi, E.E. Theodorakis, C. Doxaki, E. Lagoudaki, E. Ieronymaki, V.I. Alexaki, M. Helms, E. Kondili, B. Soennichsen, E.N. Stathopoulos, A.N. Margioris, D. Georgopoulos, C. Tsatsanis, Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice, Journal of immunology (Baltimore, Md. : 1950) 192(1) (2014) 394-406.","DOI":"10.4049\/jimmunol.1300959"},{"issue":"33","key":"10.1016\/j.bcp.2025.117372_b0365","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117372_b0370","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.intimp.2016.01.009","article-title":"MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages","volume":"32","author":"Huang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"41","key":"10.1016\/j.bcp.2025.117372_b0375","doi-asserted-by":"crossref","first-page":"17475","DOI":"10.1073\/pnas.0908641106","article-title":"A CREB-C\/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair","volume":"106","author":"Ruffell","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117372_b0380","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2019.04.011","article-title":"Long non-coding RNA: Classification, biogenesis and functions in blood cells","volume":"112","author":"Dahariya","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2025.117372_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115890","article-title":"Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets","volume":"218","author":"Arab","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117372_b0390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2015.05.012","article-title":"Basic biology and therapeutic implications of lncRNA","volume":"87","author":"Khorkova","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117372_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116900","article-title":"Mechanisms of lncRNA\/microRNA interactions in angiogenesis","volume":"254","author":"Zhao","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","article-title":"Revealing protein-lncRNA interaction","volume":"17","author":"Ferr\u00e8","year":"2016","journal-title":"Brief. Bioinform."},{"issue":"41","key":"10.1016\/j.bcp.2025.117372_b0405","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/onc.2017.184","article-title":"LncRNA-mediated regulation of cell signaling in cancer","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0410","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0415","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-022-02319-z","article-title":"LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond","volume":"41","author":"Huang","year":"2022","journal-title":"Journal of experimental & clinical cancer research : CR"},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122659","article-title":"LncRNA Structural Characteristics in Epigenetic Regulation","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117372_b0425","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0430","first-page":"e00135","volume":"7","author":"Webster","year":"2016","journal-title":"The Sponge Hologenome, mBio"},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0435","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124522","article-title":"Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury","volume":"4","author":"Cui","year":"2019","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0440","doi-asserted-by":"crossref","first-page":"13242","DOI":"10.1002\/jcp.27996","article-title":"lncRNA GAS5 promotes M1 macrophage polarization via miR-455-5p\/SOCS3 pathway in childhood pneumonia","volume":"234","author":"Chi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"21","key":"10.1016\/j.bcp.2025.117372_b0445","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1111\/jcmm.15720","article-title":"Long non-coding RNA MEG3 inhibits M2 macrophage polarization by activating TRAF6 via microRNA-223 down-regulation in viral myocarditis","volume":"24","author":"Xue","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0450","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-021-02267-z","article-title":"LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1\u03b1 expression","volume":"18","author":"Yang","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"Pt B","key":"10.1016\/j.bcp.2025.117372_b0455","article-title":"LncRNA-Cox2 regulates macrophage polarization and inflammatory response through the CREB-C\/EBP\u03b2 signaling pathway in septic mice","volume":"101","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117372_b0460","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006230","article-title":"The NR_109\/FUBP1\/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0465","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","article-title":"The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGF\u03b2 and Notch pathways","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0470","first-page":"2455","article-title":"Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGF\u03b2\/Smad signaling pathway","volume":"12","author":"Chen","year":"2019","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0475","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-024-01736-5","article-title":"N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases","volume":"16","author":"Tan","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bcp.2025.117372_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139390","article-title":"LncRNA-MEG3\/miR-93-5p\/SMAD7 axis mediates proliferative and inflammatory phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"294","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030733","article-title":"Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types","volume":"7","author":"Salzman","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0490","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0495","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-020-01179-5","article-title":"A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer","volume":"19","author":"Pan","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0500","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"41","key":"10.1016\/j.bcp.2025.117372_b0505","doi-asserted-by":"crossref","first-page":"66455","DOI":"10.18632\/oncotarget.12186","article-title":"CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis","volume":"7","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117372_b0510","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6818524","article-title":"circRNA_17725 Promotes Macrophage Polarization towards M2 by Targeting FAM46C to Alleviate Arthritis","volume":"2023","author":"Yang","year":"2023","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","article-title":"Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression","volume":"23","author":"Deng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0520","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ymthe.2021.09.017","article-title":"Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation","volume":"30","author":"Song","year":"2022","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0525","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/imm.13558","article-title":"Circular RNA ACTR2 activates M2 polarization of macrophages through activating Yes-associated protein signalling and contributes to renal fibrosis","volume":"167","author":"Fu","year":"2022","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0530","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13046-023-02916-6","article-title":"Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization","volume":"42","author":"Yao","year":"2023","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"10.1016\/j.bcp.2025.117372_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.792138","article-title":"Long Noncoding RNA and Circular RNA Expression Profiles of Monocyte-Derived Dendritic Cells in Autoimmune Hepatitis","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0540","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/2326-6066.CIR-22-0410","article-title":"Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p\/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis","volume":"11","author":"Wang","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0545","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep4.1657","article-title":"Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH","volume":"5","author":"Harrison","year":"2021","journal-title":"Hepatology communications"},{"issue":"10","key":"10.1016\/j.bcp.2025.117372_b0550","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41374-022-00807-6","article-title":"A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis","volume":"102","author":"Sakuma","year":"2022","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"issue":"46","key":"10.1016\/j.bcp.2025.117372_b0555","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.3748\/wjg.v23.i46.8140","article-title":"miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0560","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12967-025-06490-7","article-title":"Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learning","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117372_b0565","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3960197","article-title":"circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis","volume":"2017","author":"Guo","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1507\/endocrj.EJ24-0008","article-title":"Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress","volume":"72","author":"Zhou","year":"2025","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0575","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2024.10.008","article-title":"A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis","volume":"37","author":"Zhang","year":"2025","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0580","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41435-025-00334-6","article-title":"Macrophage inhibition in the alleviation of nonalcoholic steatohepatitis caused by bariatric surgery","volume":"26","author":"Zheng","year":"2025","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040283","article-title":"Molecular Mechanisms of Immune Regulation: A Review","volume":"14","author":"Arneth","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117372_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248376","article-title":"Corrigendum: Programmed cell death and lipid metabolism of macrophages in NAFLD","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117372_b0595","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231197058","article-title":"Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review","volume":"51","author":"Kan Changez","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bcp.2025.117372_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101244","article-title":"Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease","volume":"51","author":"Xu","year":"2021","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0605","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-024-05283-8","article-title":"Exosomes regulate SIRT3-related autophagy by delivering miR-421 to regulate macrophage polarization and participate in OSA-related NAFLD","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.bcp.2025.117372_b0610","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"issue":"14","key":"10.1016\/j.bcp.2025.117372_b0615","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.7150\/ijbs.57610","article-title":"Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0620","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","article-title":"Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0625","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2025.01.002","article-title":"Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair","volume":"58","author":"De Ponti","year":"2025","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0630","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030560","article-title":"LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review","volume":"13","author":"Zeng","year":"2023","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.bcp.2025.117372_b0635","first-page":"1742","article-title":"Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity, Liver international : official journal of the International Association for the Study of the","volume":"39","author":"Di Mauro","year":"2019","journal-title":"Liver"},{"key":"10.1016\/j.bcp.2025.117372_b0640","unstructured":"X. Kong, T. Zhang, Y. Zhang, L. Gao, W. Wang, M. Wang, G. Wang, K. L\u00fc, [Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease], Nan fang yi ke da xue xue bao = Journal of Southern Medical University 44(1) (2024) 1-8."},{"key":"10.1016\/j.bcp.2025.117372_b0645","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtn.2020.06.017","article-title":"lncRNA AK085865 Promotes Macrophage M2 Polarization in CVB3-Induced VM by Regulating ILF2-ILF3 Complex-Mediated miRNA-192 Biogenesis","volume":"21","author":"Zhang","year":"2020","journal-title":"Molecular therapy. Nucleic acids"},{"key":"10.1016\/j.bcp.2025.117372_b0650","doi-asserted-by":"crossref","unstructured":"Y.J. Xing, T. Zhang, S.J. Wan, Y. Cheng, S.M. Zhou, Y. Sun, H.R. Zhang, X.M. Yao, Q. Hua, X.J. Meng, Y. Zhang, K. Lv, C. Li, X. Kong, LncRNA HEM2ATM improves obesity-associated adipose tissues meta-inflammation and insulin resistance by interacting with heterogeneous nuclear ribonucleoprotein U, Clinical immunology (Orlando, Fla.) 247 (2023) 109234.","DOI":"10.1016\/j.clim.2023.109234"},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0655","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbrc.2019.02.099","article-title":"NLRC4 inflammasome activation regulated by TNF-\u03b1 promotes inflammatory responses in nonalcoholic fatty liver disease","volume":"511","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0660","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","article-title":"The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis","volume":"7","author":"Shu","year":"2021","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bcp.2025.117372_b0665","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12935-020-01354-0","article-title":"LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1\/M2 polarization of Kupffer cells","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.bcp.2025.117372_b0670","doi-asserted-by":"crossref","first-page":"14519","DOI":"10.1002\/jcp.28143","article-title":"SNHG20: A vital lncRNA in multiple human cancers","volume":"234","author":"Zhao","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117372_b0675","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/iub.2137","article-title":"Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization","volume":"71","author":"Wang","year":"2019","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0680","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1159\/000487575","article-title":"Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice","volume":"45","author":"Guo","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2025.117372_b0685","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clnu.2025.05.009","article-title":"CiR-EIS alleviates metabolic dysfunction-associated steatohepatitis by modulating macrophage polarization involving the miR-548m\/IGF1 axis","volume":"50","author":"Chen","year":"2025","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"issue":"11","key":"10.1016\/j.bcp.2025.117372_b0690","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.7150\/thno.42423","article-title":"Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p\/FBXW7 axis","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0695","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jvh.13917","article-title":"Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1\/M2 macrophage polarization","volume":"31","author":"Yang","year":"2024","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bcp.2025.117372_b0700","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/IJN.S284560","article-title":"Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.bcp.2025.117372_b0705","first-page":"454","article-title":"Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor\/Akt\/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease, Hepatology (Baltimore","volume":"72","author":"Liu","year":"2020","journal-title":"Md.)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111738","article-title":"Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p","volume":"387","author":"Zhao","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"8\u20139","key":"10.1016\/j.bcp.2025.117372_b0715","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41417-022-00432-x","article-title":"Dicer deletion in hepatocytes promotes macrophages M1 polarization through dysregulated miR-192-3p\/IGF2 in non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"29","author":"Hu","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2025.117372_b0720","doi-asserted-by":"crossref","unstructured":"H. Wade, K. Pan, B. Zhang, W. Zheng, Q. Su, Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis, eGastroenterology 2(4) (2024) e100115.","DOI":"10.1136\/egastro-2024-100115"},{"issue":"17","key":"10.1016\/j.bcp.2025.117372_b0725","doi-asserted-by":"crossref","DOI":"10.3390\/cells13171407","article-title":"Emerging Roles of Circular RNA in Macrophage Activation and Inflammatory Lung Responses","volume":"13","author":"Son","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2025.117372_b0730","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117372_b0735","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1038\/ncomms9523","article-title":"miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program","volume":"6","author":"Su","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117372_b0740","article-title":"MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6C(lo) Phenotype","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117372_b0745","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2025.117372_b0750","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ymthe.2022.03.008","article-title":"IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity","volume":"30","author":"Phu","year":"2022","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.bcp.2025.117372_b0755","article-title":"Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1\/STAT6-microRNA-23a feedback loop in macrophage M2 polarization","volume":"168","author":"Zheng","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.bcp.2025.117372_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119376","article-title":"Total saponins from Panax japonicus reduced lipid deposition and inflammation in hepatocyte via PHD2 and hepatic macrophage-derived exosomal miR-463-5p","volume":"342","author":"Yang","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117372_b0765","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1002\/ptr.8528","article-title":"Nuciferine Exerts Anti-Inflammatory Effects in Mice With Non-Alcoholic Steatohepatitis by Regulating the miR-23a-3p-SIRT1-NF-\u03baB Pathway and Akkermansia muciniphila -Extracellular Vesicles","volume":"39","author":"Zhu","year":"2025","journal-title":"Phytotherapy research : PTR"},{"issue":"13","key":"10.1016\/j.bcp.2025.117372_b0770","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-Based Diagnosis and Therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0775","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12896-016-0292-7","article-title":"A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer","volume":"16","author":"Campomenosi","year":"2016","journal-title":"BMC Biotech."},{"issue":"4","key":"10.1016\/j.bcp.2025.117372_b0780","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/wrna.1229","article-title":"MicroRNAs as therapeutic targets in human cancers","volume":"5","author":"Shah","year":"2014","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"19","key":"10.1016\/j.bcp.2025.117372_b0785","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911502","article-title":"miRNA: A Promising Therapeutic Target in Cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117372_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117372_b0795","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"Journal of drug delivery"},{"key":"10.1016\/j.bcp.2025.117372_b0800","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcis.2023.01.007","article-title":"Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment","volume":"636","author":"Wang","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117372_b0805","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1021\/acs.nanolett.6b02386","article-title":"In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40","volume":"16","author":"Sun","year":"2016","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.bcp.2025.117372_b0810","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.apsb.2020.07.019","article-title":"Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.bcp.2025.117372_b0815","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","article-title":"How macrophages deal with death","volume":"19","author":"Lemke","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"40","key":"10.1016\/j.bcp.2025.117372_b0820","doi-asserted-by":"crossref","first-page":"15919","DOI":"10.1073\/pnas.1312197110","article-title":"Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival","volume":"110","author":"Cieslewicz","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117372_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107022","article-title":"Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems","volume":"199","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:10:43Z","timestamp":1773133843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":165,"alternative-id":["S0006295225006379"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117372","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in understanding the mechanism of noncoding RNA (ncRNA)-mediated regulation of macrophage polarization in NAFLD","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117372"}}